Literature DB >> 17594285

Effect of HIV-1 infection on malaria treatment outcome in Ugandan patients.

Pauline Byakika-Kibwika1, Edward Ddumba, Moses Kamya.   

Abstract

BACKGROUND: Malaria and HIV-1 infection cause significant morbidity and mortality in sub-Saharan Africa. HIV-1 increases risk for malaria with the risk increasing as immunity declines. The effect of HIV-1 infection on antimalarial treatment outcome is still inconclusive.
OBJECTIVE: To compare antimalarial treatment outcome among HIV-1 positive and negative patients with acute uncomplicated falciparum malaria treated with chloroquine plus sulfadoxine-pyrimethamine (CQ+SP).
METHODS: Ninety eight HIV-1 positive patients aged 18 months or older with acute uncomplicated falciparum malaria were treated with CQ+SP and followed for 28 days to monitor outcome. Treatment outcome of HIV-1 positive patients was compared to that of 193 HIV-1 negative historical controls. The primary study outcome for both groups was treatment failure.
RESULTS: HIV-1 positive patients older than 5 years of age were less likely to have treatment failure compared to HIV-1 negative patients in the same age group (RR 0.59 95% CI 0.4-0.8, p < 0.001) and HIV-1 positive patients on routine cotrimoxazole prophylaxis were less likely to have treatment failure following CQ+SP treatment compared to HIV negative patients (RR 0.6 95% CI 0.43-0.92, p = 0.006). There was no difference in treatment outcome according to HIV-1 status for children younger than 5 years of age.
CONCLUSIONS: Adherence to cotrimoxazole prophylaxis should be reinforced in HIV positive patients and it should be reassessed if these patients present with acute episodes of malaria.

Entities:  

Mesh:

Year:  2007        PMID: 17594285      PMCID: PMC1925269          DOI: 10.5555/afhs.2007.7.2.86

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  27 in total

1.  HIV infection may adversely affect clinical response to chloroquine therapy for uncomplicated malaria in children.

Authors:  M R Kamya; C N Kigonya; W McFarland
Journal:  AIDS       Date:  2001-06-15       Impact factor: 4.177

2.  Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based study.

Authors:  Moses R Kamya; Anne F Gasasira; Adoke Yeka; Nathan Bakyaita; Samuel L Nsobya; Damon Francis; Philip J Rosenthal; Grant Dorsey; Diane Havlir
Journal:  J Infect Dis       Date:  2005-11-18       Impact factor: 5.226

3.  Natural history of Plasmodium falciparum malaria and determining factors of the acquisition of antimalaria immunity in two endemic areas, Dielmo and Ndiop (Senegal).

Authors:  C Rogier
Journal:  Bull Mem Acad R Med Belg       Date:  2000

4.  Predictors of chloroquine treatment failure in children and adults with falciparum malaria in Kampala, Uganda.

Authors:  G Dorsey; M R Kamya; G Ndeezi; J N Babirye; C R Phares; J E Olson; E T Katabira; P J Rosenthal
Journal:  Am J Trop Med Hyg       Date:  2000-06       Impact factor: 2.345

5.  HIV, malaria parasites, and acute febrile episodes in Ugandan adults: a case-control study.

Authors:  P Francesconi; M Fabiani; M G Dente; M Lukwiya; R Okwey; J Ouma; R Ochakachon; F Cian; S Declich
Journal:  AIDS       Date:  2001-12-07       Impact factor: 4.177

6.  HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria.

Authors:  Jean-Pierre Van Geertruyden; Modest Mulenga; Lawrence Mwananyanda; Victor Chalwe; Filip Moerman; Roma Chilengi; Webster Kasongo; Chantal Van Overmeir; Jean-Claude Dujardin; Robert Colebunders; Luc Kestens; Umberto D'Alessandro
Journal:  J Infect Dis       Date:  2006-08-29       Impact factor: 5.226

7.  Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults.

Authors:  N French; J Nakiyingi; E Lugada; C Watera; J A Whitworth; C F Gilks
Journal:  AIDS       Date:  2001-05-04       Impact factor: 4.177

8.  Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study.

Authors:  J Whitworth; D Morgan; M Quigley; A Smith; B Mayanja; H Eotu; N Omoding; M Okongo; S Malamba; A Ojwiya
Journal:  Lancet       Date:  2000-09-23       Impact factor: 79.321

Review 9.  Plasmodium falciparum clinical malaria: lessons from longitudinal studies in Senegal.

Authors:  C Rogier; A Tall; N Diagne; D Fontenille; A Spiegel; J F Trape
Journal:  Parassitologia       Date:  1999-09

10.  Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine.

Authors:  J K Iyer; W K Milhous; J F Cortese; J G Kublin; C V Plowe
Journal:  Lancet       Date:  2001-09-29       Impact factor: 79.321

View more
  8 in total

1.  Artemisinin-based combination therapies are efficacious and safe for treatment of uncomplicated malaria in HIV-infected Ugandan children.

Authors:  Abel Kakuru; Jane Achan; Mary K Muhindo; Gloria Ikilezi; Emmanuel Arinaitwe; Florence Mwangwa; Theodore Ruel; Tamara D Clark; Edwin Charlebois; Philip J Rosenthal; Diane Havlir; Moses R Kamya; Jordan W Tappero; Grant Dorsey
Journal:  Clin Infect Dis       Date:  2014-04-23       Impact factor: 9.079

2.  Update on the efficacy, effectiveness and safety of artemether-lumefantrine combination therapy for treatment of uncomplicated malaria.

Authors:  Pauline Byakika-Kibwika; Mohammed Lamorde; Harriet Mayanja-Kizza; Concepta Merry; Bob Colebunders; Jean-Pierre Van Geertruyden
Journal:  Ther Clin Risk Manag       Date:  2010-02-02       Impact factor: 2.423

3.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04

4.  Malaria and HIV among pediatric inpatients in two Tanzanian referral hospitals: A prospective study.

Authors:  Luke R Smart; Neema Orgenes; Humphrey D Mazigo; Mercy Minde; Adolfine Hokororo; Muhammad Shakir; Jaco J Verweij; Jennifer A Downs; Robert N Peck
Journal:  Acta Trop       Date:  2016-03-18       Impact factor: 3.112

5.  Low prevalence of Plasmodium falciparum antigenaemia among asymptomatic HAART-treated adults in an urban cohort in Uganda.

Authors:  Damalie Nakanjako; Agnes N Kiragga; Barbara Castelnuovo; Daniel J Kyabayinze; Moses R Kamya
Journal:  Malar J       Date:  2011-03-22       Impact factor: 2.979

6.  Should we care about Plasmodium vivax and HIV co-infection? A systematic review and a cases series from the Brazilian Amazon.

Authors:  Paola López Del-Tejo; Nadia Cubas-Vega; Cecilia Caraballo-Guerra; Bernardo Maia da Silva; Jefferson da Silva Valente; Vanderson Souza Sampaio; Djane Clarys Baia-da-Silva; Daniel Barros Castro; Flor Ernestina Martinez-Espinosa; André Machado Siqueira; Marcus Vinícius Guimarães Lacerda; Wuelton Marcelo Monteiro; Fernando Val
Journal:  Malar J       Date:  2021-01-06       Impact factor: 2.979

Review 7.  Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review.

Authors:  Christine Manyando; Eric M Njunju; Umberto D'Alessandro; Jean-Pierre Van Geertruyden
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

8.  Outcome of artemether-lumefantrine treatment for uncomplicated malaria in HIV-infected adult patients on anti-retroviral therapy.

Authors:  Betty A Maganda; Omary M S Minzi; Appolinary A R Kamuhabwa; Billy Ngasala; Philip G Sasi
Journal:  Malar J       Date:  2014-05-30       Impact factor: 2.979

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.